Nootropics and metabolically active compounds in Alzheimer's disease.

Gold, P. E. (1986) Behav. Neural Biol. 46,87-98 Jensen, L. H., Petersen, E. N., Braestrup, C., Honore, T., Kehr, W., Stephens, D. N., Seidelmann, D. & Schmiechen, R. (1984) I-’sycliopharmricologyo~ 83,2492 5 6 Jensen, L. H., Stephens, D. N., Sarter, M. & Petersen, E. N. ( 1 987) Bruin. Res. Bull. 19, 359-364 Petkow, V., Georgier, V., Getova, D. & Petkov, V. (1983) Acfu I’hysiol. I’harmacol. Bulg. 9, 313 Procter, A. W. & Bowen, D. M. (1988) Trend3 Neurosci. 11, 20 8-209 Richardson, J. S., Miller, P. S., Lemay, J. S., Jyu . C. A,, Neil, S. G., Kilduff, C. J. & Keegan, D. L. (1985) Prog. Neuro-l’sychopharmacol. Biol. I’sychiufr. 9,65 1-654 Roehrs, T., Zorick, F. J., Siclesteel, J. M., Wittig. R. M., Hartse, K. A. & Roth, T. ( 1 983) J . Clin. I’sychopharmocol. 3,3 10-3 I3 Sarter, M. ( 1987) Int. J . Neurosci. 32,765-774 Sarter, M. & Markowitsch, H. J . (1983) Neiirobiol. Aging 4,